3
Christensen, S. B. Bioorg. Med. Chem. 2010, 18, 5634–5646; f)
Paulsen, E. S.; Villadsen, J.; Tenori, E.; Liu, H.; Bonde, D. F.; Lie,
M. A.; Bublitz, M.; Olesen, C.; Autzen, H. E.; Dach, I.; Sehgal,
R.; Nissen, P.; Møller, J. V.; Schiott, B.; Christensen, S. B. J.
Med. Chem. 2013, 56, 3609–3619.
a) Thastrup, O.; Cullen, P. J.; Drøbak, B. K.; Hanley, M. R.;
Dawson, A. P. Proc. Nat. Acad. Sci. 1990, 87, 2466-2470; b)
Davidson, G. A.; Varhol, R. J. J. Biol. Chem. 1995, 270, 11731-
11734.
Doan, N. T. Q.; Paulsen, E. S.; Sehgal, P.; Møller, J. V.; Nissen,
P.; Denmeade, S. R.; Isaacs, J. T.; Dionne, C. A.; Christensen, S.
B. Steroids 2015, 97, 2–7.
Denmeade, S. R.; Mhaka, A. M.; Rosen, D. M.; Brennen, W. N.;
Dalrymple, S.; Dach, I.; Olesen, C.; Gurel, B.; DeMarzo, A. M.;
Wilding, G.; Carducci, M. A.; Dionne, C. A.; Møller, J. V.;
Nissen, P.; Christensen, S. B.; Isaacs, J. T. Sci. Transl. Med. 2012,
4, 140ra86.
10. a) Uyanik, M.; Suzuki, D.; Yasui, T.; Ishihara, K. Angew. Chem.
Int. Ed. 2011, 50, 5331–5334; b) Uyanik, M.; Ishihara, K.
ChemCatChem 2012, 4, 177–185.
11. a) Beshara, C. S.; Hall, A.; Jenkins, R. L.; Jones, K. L.; Jones, T.
C.; Killeen, N. M.; Taylor, P. H.; Thomas, S. P.; Tomkinson, N.
C. O. Org. Lett. 2005, 7, 5729–5732; b) Smithen, D. A.; Mathews,
C. J.; Tomkinson, N. C. O. Org. Biomol. Chem. 2012, 3756–3762.
12. a) Heiba, E. I.; Dessau, R. M.; Koehl, W. J., Jr. J. Am. Chem. Soc.
1969, 91, 138–145; b) Demir, A. S.; Jeganathan, A.; Watt, D. S. J.
Org. Chem.1989, 54, 4020–4022; Akdağ, A.; Tarkan, O.; Türker,
L. J. Mol. Struct. Theochem 2001, 571, 201–206; d) Demir, A. S.;
Reis, O.; Cigdem Igdir, A. Tetrahedron 2004, 60, 3427–3432.
13. A mixture of starting material 4 and the corresponding 2-acetoxy
ketone derivative were also recovered after purification. These two
compounds coelute and cannot be separated by chromatography
on silica gel. For more details, see ESI as well as ref 8.
2.
3.
4.
14. Andersen, A.; Cornett, C.; Lauridsen, A.; Olsen, C. E.;
Christensen, S. B. Acta Chem. Scand. 1994, 48, 340–346.
15. a) Nakata, T.; Tanaka, T.; Oishi, T. Tetrahedron Lett. 1983, 24,
2653–2656; b) Oishi, T.; Nakata, T. Acc. Chem. Res. 1984, 17,
338–344.
5.
6.
Santana, A.; Molinillo, J. M. G.; Macías, F. A. Eur. J. Org. Chem.
2015, 2093–2110.
Andrews, S. P.; Ball, M.; Wierschem, F.; Cleator, E.; Oliver, S.;
Hoegenauer, K.; Simic, O.; Antonello, A.; Huenger, U.; Smith, M.
D.; Ley, S. V. Chem. – Eur. J. 2007, 13, 5688–5712 and
references therein.
16. Two other by-products were obtained during the reduction with
zinc borohydride in THF. For more details, see ESI.
7.
a) Smitt, U. W.; Christensen, S. B. Planta.Med. 1991, 57, 196–
197; b) Christensen, S. B.; Andersen, A.; Smitt, U. W. Progr.
Chem. Natl. Prod. 1997, 71, 131–167; c) Drew, D. P.; Krichau,
N.; Reichwald, K.; Simonsen, H. T. Phytochem. Rev. 2009, 8,
581–599; d) Holub, M.; de Groote, R.; Herout, V.; Sorm, F. Coll.
Czech. Chem Commun. 1968, 33, 2911 – 2917. e) The amount of
nortrilobolide isolated from T. garganica is 210 mg from 30 g of
fruits which represents less than 0.1%, see ref 7a. Trilobolide, in
which the butanoyl residue of nortrilobolide is substituted with -
methylbutanoyl is isolated from roots of cultivated Laser trilobum
in a yield of 0.5 %, see ref. 7d.
17. The mixed angelic anhydride was prepared according to a
modified procedure described in: Liang, X.; Grue-Sørensen, G.;
Petersen, A. K.; Högberg, T. Synlett 2012, 2647–2652. Moreover,
starting material 6S (12%) was also recovered after purification by
column chromatography.
Supplementary Material
Experimental procedures and copies of NMR spectra for all
relevant synthesized compounds.
8.
9.
Doan, N. T. Q.; Crestey, F.; Olsen, C. E.; Christensen, S. B. J.
Nat. Prod. 2015, 78, 1406–1414.
Rawlinson, D. J.; Sosnovsky, G. Synthesis 1973, 567–603.